DekaBank Deutsche Girozentrale - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$431
-24.1%
28,3000.0%0.00%0.0%
Q2 2023$568
-0.7%
28,3000.0%0.00%0.0%
Q1 2023$572
-16.3%
28,3000.0%0.00%
-50.0%
Q4 2022$683
-99.9%
28,3000.0%0.00%0.0%
Q3 2022$687,000
+29.9%
28,3000.0%0.00%0.0%
Q2 2022$529,000
+8.4%
28,3000.0%0.00%
+100.0%
Q1 2022$488,000
-8.6%
28,300
+10.1%
0.00%0.0%
Q4 2021$534,000
+11.0%
25,700
+2.8%
0.00%0.0%
Q3 2021$481,000
+12.6%
25,0000.0%0.00%0.0%
Q2 2021$427,000
-17.4%
25,0000.0%0.00%
-50.0%
Q1 2021$517,000
-10.1%
25,0000.0%0.00%0.0%
Q4 2020$575,00025,0000.00%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 8,076$174,5220.01%
MASSMUTUAL TRUST CO FSB/ADV 46$9940.00%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders